Business Context and Reporting Period
This Form 8-K reports the results of the 2021 Annual Meeting of Stockholders for Artelo Biosciences, Inc., held on July 16, 2021. The meeting was originally scheduled for June 18, 2021, but was adjourned due to a lack of quorum. The reconvened meeting successfully achieved a quorum with approximately 46.40% of outstanding shares represented.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. Investors should refer to the company's most recent 10-K or 10-Q filings for financial performance details.
Material Changes and Voting Results
The primary material event reported is the successful completion of the Annual Meeting following an adjournment. Key voting outcomes include:
- Adjournment Proposal: Approved on June 18, 2021, with 866,833 votes For and 0 Against.
- Quorum Achievement: The July 16 meeting had 10,742,268 shares represented (46.40% of 23,149,112 outstanding shares).
- Election of Directors: All eight nominees were elected. Notable vote counts included:
- R. Martin Emanuele, Ph.D.: 5,605,698 For, 161,745 Against.
- Gregory R. Reyes, M.D., Ph.D.: 5,601,921 For, 154,169 Against.
- Steven Kelly: 5,364,588 For, 397,248 Against (highest "Against" vote count).
- Ratification of Auditors: MaloneBailey, LLP was ratified as the independent registered public accounting firm with 9,632,130 votes For and 499,884 votes Against.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It also does not disclose new risks, contingencies, or unusual items beyond the procedural delay in holding the Annual Meeting.
Key Facts for Investor Verification
- Verify the total number of shares outstanding (23,149,112) against the company's latest cap table or 10-Q.
- Review the specific reasons for the initial failure to achieve quorum on June 18, 2021, to assess shareholder engagement levels.
- Confirm the tenure of the newly elected directors, who serve until the 2022 annual meeting.
- Check subsequent filings for the appointment of MaloneBailey, LLP for the fiscal year ending August 31, 2021, and the stub period through December 31, 2021.